Call for Abstract
Scientific Program
4th International Congress on Viral Hepatitis, will be organized around the theme “Raising global awareness on screening and prevention of hepatitis”
Hepatitis 2018 is comprised of 15 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Hepatitis 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.
Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.
Hepatitis A is an acute infection of the liver caused by the hepatitis A virus. Vaccination against hepatitis A is available. Hepatitis D is a liver disease caused by the hepatitis D virus, (also called delta virus) a defective virus that needs the hepatitis B virus to exist. Infection with hepatitis D can be prevented by hepatitis B vaccine. Hepatitis E is an acute illness but does not cause a chronic infection. It is transmitted via the faecal-oral route and can be spread by eating or drinking contaminated food or water.
The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.
The aim of the clinical research studies is to learn more about the hepatitis C virus, how it replicates, what causes the damage to the liver and what role the immune system plays in the disease. Research in Hepatitis is becoming increasingly important as millions of people are afflicted with hepatitis each year.
Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes). Acute hepatitis damages hepatocytes, make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival.
Hepatitis virus infection is a global public health problem. The implementation of effective vaccination programs in many countries has resulted in a significant decrease in the incidence of hepatitis. During the acute phase, manifestations range from subclinical or anicteric hepatitis to icteric hepatitis and, in some cases, fulminant hepatitis. During the chronic phase, manifestations range from an asymptomatic carrier state to chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.
Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. Producing bile and removing toxins are the important roles played by the liver. There are over 100 different forms of liver disease that affect men, women and children.
The metabolic liver diseases in adults include and iron overload (hemochromatosis), Wilson disease and alpha 1-antitrypsin deficiency. The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).
Hepato-pancreato-biliary disease refers to any condition that affects the liver, pancreas, gallbladder, and the bile ducts. These diseases show common symptoms such as jaundice, darker urine colour, and lighter stool colour.
Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.
Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.
Gastroenterology focuses on digestive system and its disorders which include various organs from mouth to anus, along the alimentary canal. It involves a detailed understanding of the physiology of the gastrointestinal organs including the motility of food through the stomach and intestine, the digestion and absorption of nutrients into the body, removal of waste from the system, and the function of the liver as a digestive organ.
Overall, about one-third of people with HIV also have hepatitis C. Hepatitis C virus (HCV) can be transmitted in some of the same ways as HIV and hepatitis B. HIV can worsen hepatitis C. HIV not only increase the risk of liver damage, but it can also speed up the onset of liver damage following infection. People who are coinfected with HIV and HCV should work closely with health care providers in order to monitor and treat both conditions.